British laboratory AstraZeneca believes it will be able to deliver a billion doses of a potential Covid-19 vaccine this year and next.
AstraZeneca believes it will be able to deliver a billion doses of a potential COVID-19 vaccine this year and next if the trials are successful and the UK lab said on Thursday it has secured more than $ 1 billion in funding. the US administration for this research.
In a press release, the group announces that it has already signed agreements for the supply of at least 400 million doses of its potential vaccine, developed with the University of Oxford.
The US Department of Health has ordered 300 million
The US Department of Health said it has ordered 300 million doses of this vaccine under development, with the hope of obtaining them from October.
AstraZeneca has said it will soon know the results of the first clinical trials. If they are conclusive, the laboratory will move on to a new phase of testing in several countries.
There is currently no validated vaccine or treatment for COVID-19, the disease caused by the new coronavirus that appeared in China in December.
The large laboratories, including Sanofi, each carry out their own research and are at different stages in the development of such a vaccine.
Read also Vaccine: Sanofi tries to clear the land, against a backdrop of controversy over health sovereignty